Results 191 to 200 of about 51,116 (225)
To assess tolerability and optimal time point for initiation of sacubitril/valsartan in patients stabilised after acute heart failure (AHF).
Rolf Wachter +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Circulation, 2020
July 7, 2020 e3 Kai Wu, MD Song Zhao, PhD To the Editor: We read with interest the study by McMurray et al1 evaluating the effects of sacubitril-valsartan, versus valsartan, in women and men with heart failure and preserved ejection fraction. The results
Kai Wu, Song Zhao
semanticscholar +1 more source
July 7, 2020 e3 Kai Wu, MD Song Zhao, PhD To the Editor: We read with interest the study by McMurray et al1 evaluating the effects of sacubitril-valsartan, versus valsartan, in women and men with heart failure and preserved ejection fraction. The results
Kai Wu, Song Zhao
semanticscholar +1 more source

